Eli Lilly : LLY

All Eli Lilly Articles

618 Articles

Rich Duprey | Feb 24, 2025 at 12:36 PM EST

HIMS is Out. Is Novo Nordisk or Eli Lilly the Better GLP-1 Buy?

The Food & Drug Administration announced last week that the Ozempic and Wegovy shortage for Novo Nordisk‘s (NYSE:NVO | NVO…

Chris MacDonald | Feb 21, 2025 at 12:47 PM EST

This Growth Stock Surged 63% in 2024. Here’s Why 2025 Could Bring An Even Bigger Gain.

The big pharma sector is one that’s generally fallen out of favor for many investors over the past few decades,…

Ian Cooper | Feb 21, 2025 at 11:47 AM EST

Hims & Hers (HIMS) Down 21% – Is the GLP-1 Gravy Train Over?

Shares of Hims & Hers Health (NYSE:HIMS) are down about 21%, or $14. All on news the Ozempic shortage is…

Rich Duprey | Feb 19, 2025 at 9:41 AM EST

2 Surprising Stocks That Could Be Hurt By Trump’s European Tariffs

President Trump is going scorched earth on America’s major European trading partners. Vowing to impose reciprocal tariffs on “every country”…

Trey Thoelcke | Feb 14, 2025 at 8:45 AM EST

AbbVie Just Paid Investors: Here’s How Much They Received

AbbVie just rewarded its shareholders again with a dividend. This stock has boosted its payout annually for more than 50…

Chris MacDonald | Feb 10, 2025 at 10:14 AM EST

My 3 Top Picks for Stocks That Could Double Over the Next 3 Years

Finding stocks with the potential to double in just three years is no easy feat, even in this bull market.…

Rich Duprey | Jan 31, 2025 at 11:18 AM EST

AbbVie (ABBV) Earnings Live: Why The Stock Is Up Big Today

Shares of AbbVie (NYSE:ABBV | ABBV Price Prediction) are surging 7% this morning after the pharmaceutical giant reported solid fourth…

Joey Frenette | Jan 23, 2025 at 12:01 PM EST

I Was Convinced Biotech Stocks Were Too Risky—This Innovation’s Changing the Game

The biotech scene can be seen as fairly risky for new investors who want to put money to work. After…

Omor Ibne Ehsan | Jan 22, 2025 at 11:15 AM EST

This Best-of-Class Pharma Stock Could Soar 72% This Year According to Wall Street Insider

Eli Lilly (NYSE: LLY | LLY Price Prediction) doesn’t really need much of an introduction. It has become a household…

Rich Duprey | Jan 21, 2025 at 3:15 PM EST

Billionaire Sold Palantir and Is Buying This Stock That Could Soar 237%, According to a Wall Street Expert

Palantir Technologies (NASDAQ:PLTR | PLTR Price Prediction) has been described as the best pure-play stock in artificial intelligence. The market…

Rich Duprey | Jan 15, 2025 at 9:06 AM EST

Down 23%, Is This Dividend Giant a Buy After GLP-1 Sales Miss?

Next to artificial intelligence, weight-loss drugs have been one of the biggest themes investors latched onto in 2024. Eli Lilly…

Eric Bleeker | Jan 8, 2025 at 11:09 AM EST

Stock Market Today: Nasdaq Composite Falls & Quantum Computing Stocks Collapse (RGTI, IONQ, QUBT)

As of 10:25 a.m. ET, stocks are largely in the red today. An interest rate-fueled sell-off began yesterday that pushed…

Trey Thoelcke | Jan 8, 2025 at 7:45 AM EST

Merck Just Paid Investors: How Much Did They Receive?

Merck just rewarded its shareholders again with a dividend hike. This Dow Jones industrial stock has come with a quarterly…

Chris MacDonald | Dec 18, 2024 at 11:13 AM EST

This Feels Like the Post-Pandemic Rally. 3 Stocks to Buy If It Is

The incredible returns equity investors have seen in 2024, and over the past couple months for that matter, have been…

Omor Ibne Ehsan | Dec 17, 2024 at 8:58 AM EST

Should You Buy the 3 Highest Yielding Dividend Stocks in the Dow Jones?

The Dow Jones is one of Wall Street’s most iconic benchmarks and it tracks 30 of America’s largest companies. It…

1 … 5 6 7 8 9 … 42

Eli Lilly : LLY

All Eli Lilly Articles

HIMS is Out. Is Novo Nordisk or Eli Lilly the Better GLP-1 Buy?

This Growth Stock Surged 63% in 2024. Here’s Why 2025 Could Bring An Even Bigger Gain.

Hims & Hers (HIMS) Down 21% – Is the GLP-1 Gravy Train Over?

2 Surprising Stocks That Could Be Hurt By Trump’s European Tariffs

AbbVie Just Paid Investors: Here’s How Much They Received

My 3 Top Picks for Stocks That Could Double Over the Next 3 Years

AbbVie (ABBV) Earnings Live: Why The Stock Is Up Big Today

I Was Convinced Biotech Stocks Were Too Risky—This Innovation’s Changing the Game

This Best-of-Class Pharma Stock Could Soar 72% This Year According to Wall Street Insider

Billionaire Sold Palantir and Is Buying This Stock That Could Soar 237%, According to a Wall Street Expert

Down 23%, Is This Dividend Giant a Buy After GLP-1 Sales Miss?

Stock Market Today: Nasdaq Composite Falls & Quantum Computing Stocks Collapse (RGTI, IONQ, QUBT)

Merck Just Paid Investors: How Much Did They Receive?

This Feels Like the Post-Pandemic Rally. 3 Stocks to Buy If It Is

Should You Buy the 3 Highest Yielding Dividend Stocks in the Dow Jones?

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Eli Lilly : LLY

All Eli Lilly Articles

HIMS is Out. Is Novo Nordisk or Eli Lilly the Better GLP-1 Buy?

This Growth Stock Surged 63% in 2024. Here’s Why 2025 Could Bring An Even Bigger Gain.

Hims & Hers (HIMS) Down 21% – Is the GLP-1 Gravy Train Over?

2 Surprising Stocks That Could Be Hurt By Trump’s European Tariffs

AbbVie Just Paid Investors: Here’s How Much They Received

My 3 Top Picks for Stocks That Could Double Over the Next 3 Years

AbbVie (ABBV) Earnings Live: Why The Stock Is Up Big Today

I Was Convinced Biotech Stocks Were Too Risky—This Innovation’s Changing the Game

This Best-of-Class Pharma Stock Could Soar 72% This Year According to Wall Street Insider

Billionaire Sold Palantir and Is Buying This Stock That Could Soar 237%, According to a Wall Street Expert

Down 23%, Is This Dividend Giant a Buy After GLP-1 Sales Miss?

Stock Market Today: Nasdaq Composite Falls & Quantum Computing Stocks Collapse (RGTI, IONQ, QUBT)

Merck Just Paid Investors: How Much Did They Receive?

This Feels Like the Post-Pandemic Rally. 3 Stocks to Buy If It Is

Should You Buy the 3 Highest Yielding Dividend Stocks in the Dow Jones?

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Featured Reads

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do